For: | Knight V, Lourensz D, Tchongue J, Correia J, Tipping P, Sievert W. Cytoplasmic domain of tissue factor promotes liver fibrosis in mice. World J Gastroenterol 2017; 23(31): 5692-5699 [PMID: 28883694 DOI: 10.3748/wjg.v23.i31.5692] |
---|---|
URL: | https://www.wjgnet.com/1007-9327/full/v23/i31/5692.htm |
Number | Citing Articles |
1 |
Niccolò Bitto, Eleonora Liguori, Vincenzo La Mura. Coagulation, Microenvironment and Liver Fibrosis. Cells 2018; 7(8): 85 doi: 10.3390/cells7080085
|
2 |
Katarina Zmajkovicova, Yasmina Bauer, Katalin Menyhart, Marie Schnoebelen, Diego Freti, Maxime Boucher, Bérengère Renault, Rolf Studer, Magdalena Birker-Robaczewska, Axel Klenk, Oliver Nayler, John Gatfield, Oliver Eickelberg. GPCR-induced YAP activation sensitizes fibroblasts to profibrotic activity of TGFβ1. PLOS ONE 2020; 15(2): e0228195 doi: 10.1371/journal.pone.0228195
|
3 |
Niccolò Bitto, Gabriele Ghigliazza, Stanislao Lavorato, Camilla Caputo, Vincenzo La Mura. Improving Management of Portal Hypertension: The Potential Benefit of Non-Etiological Therapies in Cirrhosis. Journal of Clinical Medicine 2023; 12(3): 934 doi: 10.3390/jcm12030934
|
4 |
Xiaoping Ma, Zhen Liu, Yan Yu, Yaozhang Jiang, Chengdong Wang, Zhicai Zuo, Shanshan Ling, Ming He, Sanjie Cao, Yiping Wen, Qin Zhao, Rui Wu, Xiaobo Huang, Zhijun Zhong, Guangneng Peng, Yu Gu. Microsporum gypseum Isolated from Ailuropoda melanoleuca Provokes Inflammation and Triggers Th17 Adaptive Immunity Response. International Journal of Molecular Sciences 2022; 23(19): 12037 doi: 10.3390/ijms231912037
|
5 |
Li Li, Lei Zhang, Xiongqi Zhao, Jun Cao, Jingfeng Li, Guang Chu. Downregulation of miR‑152 contributes to the progression of liver fibrosis via targeting Gli3 in�vivo and in�vitro. Experimental and Therapeutic Medicine 2019; doi: 10.3892/etm.2019.7595
|
6 |
Rehab S. Abdelrahman, Ghada S. El-Tanbouly. Protocatechuic acid protects against thioacetamide-induced chronic liver injury and encephalopathy in mice via modulating mTOR, p53 and the IL-6/ IL-17/ IL-23 immunoinflammatory pathway. Toxicology and Applied Pharmacology 2022; 440: 115931 doi: 10.1016/j.taap.2022.115931
|
7 |
Yichi Zhang, Ruini Li, Weiwei Rong, Mingzi Han, Chenghu Cui, Zhenning Feng, Xiaoli Sun, Shizhu Jin. Therapeutic effect of hepatocyte growth factor-overexpressing bone marrow-derived mesenchymal stem cells on CCl4-induced hepatocirrhosis.. Cell Death & Disease 2018; 9(12) doi: 10.1038/s41419-018-1239-9
|
8 |
Hanna Oh, Hye Eun Park, Min Su Song, HaYoung Kim, Jea-Hyun Baek. The Therapeutic Potential of Anticoagulation in Organ Fibrosis. Frontiers in Medicine 2022; 9 doi: 10.3389/fmed.2022.866746
|
9 |
Marta Brambilla, Federica Fumoso, Maria Conti, Alessia Becchetti, Silvia Bozzi, Tatiana Mencarini, Piergiuseppe Agostoni, Maria E. Mancini, Nicola Cosentino, Alice Bonomi, Kevin Nallio, Arianna Galotta, Martino Pengo, Elena Tortorici, Miriam Bosco, Franco Cernigliaro, Chistian Pinna, Daniele Andreini, Marina Camera. Low-Grade Inflammation in Long COVID Syndrome Sustains a Persistent Platelet Activation Associated With Lung Impairment. JACC: Basic to Translational Science 2024; doi: 10.1016/j.jacbts.2024.09.007
|
10 |
Maha M. Shouman, Rania M. Abdelsalam, Mahmoud M. Tawfick, Sanaa A. Kenawy, Mona M. El-Naa. Antisense Tissue Factor Oligodeoxynucleotides Protected Diethyl Nitrosamine/Carbon Tetrachloride-Induced Liver Fibrosis Through Toll Like Receptor4-Tissue Factor-Protease Activated Receptor1 Pathway. Frontiers in Pharmacology 2021; 12 doi: 10.3389/fphar.2021.676608
|
11 |
Li Li, Jianghua Ran, Lan Li, Gang Chen, Shengning Zhang, Yingjia Wang. Gli3 is a novel downstream target of miR‑200a with an anti‑fibrotic role for progression of liver fibrosis in�vivo and in�vitro. Molecular Medicine Reports 2020; doi: 10.3892/mmr.2020.10997
|